Re: Bear

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fuzzyjr

Rank: Vice President [?]

Points: 5020 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Bear

in response to

Bear

Telepanel

posted on Oct 09, 2020 11:33AM

1) Yes they have.Need more patients tho - bigger longer trial(s)

2) Yes but we will take colab with BMS, now we have 3 or 4 (if include Newsoara), so DM creating competitive tension, next best thing to outright sale

3) Yes, like rvx anything is possible.

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply